Coalesce bolsters its core team with former Vectura employees.

Drug delivery device developer Coalesce Product Development Limited has further strengthened its OINDP capabilities with the recent appointment of Stephen Eason as Strategic Advisor and IP Consultant, and Mike Newton as Engineering Consultant.

Stephen and Mike were part of the Vivid Medical device team acquired by Vectura from Cambridge Consultants in 2002. Until recently, Stephen was Senior Director, Device & Technology Development, and Mike was Director, Device Industrialisation. During their time at Vectura Group PLC, they were integral to the growth and success of the business.

“We’ve known Stephen and Mike for many years and we are very excited to be working with them again. The specific knowledge and expertise that they bring enhances our growing capability in the drug delivery device space. As Coalesce continues to invest in infrastructure and human resources, and as we build reputation in the industry, Coalesce is emerging as a compelling option for pharmaceutical companies searching for turnkey drug delivery device development partners”, commented David Ahern, Founder and CEO of Coalesce.

Coalesce Chairman, and Vectura’s former Director of IP and Corporate Affairs, Dr Colin Dalton commented, “We are delighted to be welcoming Stephen and Mike to Coalesce. They will be providing their invaluable support at a very exciting time as we continue to grow the business.”